It is possible that these novel properties of DYRK1A may account for, or at least contribute to, the beneficial effects of Lithium treatment in the Ts65Dn DS mouse model reported by Contestabile et al. 63. This evidence concerns the gene DYRK1A and Dravet syndrome.